La Puente Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in La Puente
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
La Puente News
Winter storms blanket the East, while the US West is wondering: Where's the snow?
Ski season is here, but while the eastern half of the U.S. digs out from winter storms, the western U.S. snow season has been off to a very slow start.
Trying to move more? Expert explains the benefits of counting steps
Mackenzie Long, a personal trainer in physical therapy and sports medicine at the Mayo Clinic Health System in La Crosse and Onalaska, Wisconsin, explains the health benefits of tracking steps.
French antitrust watchdog dismisses complaint filed against Microsoft
The French antitrust watchdog on Thursday dismissed a complaint filed against Microsoft by local search engine Qwant ...
Regulatory, patent barriers may hinder global access to new HIV prevention drug: activists
Activists urge India to waive clinical trial requirements for lenacapavir, as patent barriers threaten access to the vital HIV prevention drug.